Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19

Description

The purpose of the study is to design and execute a prospective, longitudinal, descriptive cohort study in a pragmatic clinical practice for adults with symptoms that may be related to COVID-19.

Conditions

Coronavirus Infection

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of the study is to design and execute a prospective, longitudinal, descriptive cohort study in a pragmatic clinical practice for adults with symptoms that may be related to COVID-19.

Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19: A Descriptive, Longitudinal, Pragmatic Cohort Study

Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19

Condition
Coronavirus Infection
Intervention / Treatment

-

Contacts and Locations

Seattle

Seattle Intstitute of East Asian Medicine, Seattle, Washington, United States, 98108

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Eighteen year of age.
  • * Experienced one or more of the following symptoms in the last 28 days: cough, fever, shortness of breath, diarrhea, nausea, or abdominal pain OR am at high risk of exposure.
  • * Have a Primary Care Provider.
  • * Breastfeeding, pregnant, or expect that I might be pregnant.
  • * Ineligible to receive a telehealth consult for any reason.
  • * Unable to communicate in English verbally, and in writing.
  • * Have an open legal case about my health.
  • * Taking anticoagulants, immunosuppressants, antiseizure medications, antipsychotic medications or am in active cancer treatment
  • * Taking medications with some risk of interaction with the herbal medicine. This will be determined at the time of the herbal consult by the clinic team.
  • * Discretion of the practitioner or screener.

Ages Eligible for Study

18 Years to 114 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Center for Integrated Care,

Lisa Taylor-Swanson, PhD, PRINCIPAL_INVESTIGATOR, University of Utah

Lisa Conboy, DSc, PRINCIPAL_INVESTIGATOR, Beth Israel Deaconness Medical Center, Harvard Medical School

Study Record Dates

2025-05-11